Thyroid (USP) 15 MG Oral Tablet [Niva Thyroid] — RxCUI 2642818
RxNorm drug concept · Semantic branded drug
RxCUI 2642818
Semantic branded drug · SBD
● Current RxNorm concept 8 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2642818
Official nameThyroid (USP) 15 MG Oral Tablet [Niva Thyroid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNiva Thyroid 1/4 grain Oral Tablet; Niva Thyroid 15 MG (1/4 grain) Oral Tablet; Niva Thyroid (levothyroxine sodium 9.5 MCG / liothyronine sodium 2.25 MCG) Oral Tablet
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)2,235 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Thyroid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Desiccated thyroid — the active ingredient in products like Amerithroid and Thyroid Tablets — is made from dried pig (porcine) thyroid glands. It naturally contains...
- What exactly is desiccated thyroid, and is it different from the synthetic thyroid hormone my friend takes?
- It does matter a bit. Fasting actually increases the absorption of thyroid hormones, so many people take their tablet first thing in the morning, about 30–60 minutes before eating....
- Can I take my thyroid tablet with breakfast, or does it matter?
🕸️ Concept Web — How Thyroid (USP) 15 MG Oral Tablet [Niva Thyroid] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Thyroid (USP) 15 MG Oral Tablet [Niva Thyroid]
RxCUI 2642818 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thyroid (USP)
10572IN
-
Thyroid (USP)
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Niva Thyroid
2642811BN
-
Niva Thyroid
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thyroid (USP) Oral Tablet
374122SCDF -
Thyroid (USP) Oral Product
1162082SCDG -
Thyroid (USP) Pill
1162083SCDG -
Thyroid (USP) Oral Tablet [Niva Thyroid]
2642815SBDF -
Niva Thyroid Oral Product
2642813SBDG -
Niva Thyroid Pill
2642814SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Thyroid (USP) Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thyroid (USP) 15 MG Oral Tablet
314267SCD -
Thyroid (USP) 15 MG
316823SCDC -
Thyroid (USP) 15 MG [Niva Thyroid]
2642817SBDC
-
Thyroid (USP) 15 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thyroid (USP) 15 MG Oral Tablet
SCD · 314267 -
Thyroid (USP) 15 MG
SCDC · 316823 -
Thyroid (USP) Oral Tablet
SCDF · 374122 -
Thyroid (USP) Oral Product
SCDG · 1162082 -
Thyroid (USP) Pill
SCDG · 1162083
Brand-Name Concepts
-
Thyroid (USP) 15 MG [Niva Thyroid]
SBDC · 2642817 -
Thyroid (USP) Oral Tablet [Niva Thyroid]
SBDF · 2642815 -
Niva Thyroid Oral Product
SBDG · 2642813 -
Niva Thyroid Pill
SBDG · 2642814 -
Niva Thyroid
BN · 2642811
📦 FDA Products & Package NDCs
8 products · 8 package NDCs
8 package NDCs map to RxCUI 2642818 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 75834-0310-01 | 100 TABLET in 1 BOTTLE (75834-310-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0311-01 | 100 TABLET in 1 BOTTLE (75834-311-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0312-01 | 100 TABLET in 1 BOTTLE (75834-312-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0313-01 | 100 TABLET in 1 BOTTLE (75834-313-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0314-01 | 100 TABLET in 1 BOTTLE (75834-314-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0315-01 | 100 TABLET in 1 BOTTLE (75834-315-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0316-01 | 100 TABLET in 1 BOTTLE (75834-316-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0317-01 | 100 TABLET in 1 BOTTLE (75834-317-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
Observed labelers:
Nivagen Pharmaceuticals, Inc. (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.